Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Infectious Uveitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00333996
What this trial is testing

The Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis

Who this might be right for
Anterior Uveitis
Allergan 5
Not applicableStudy completedNCT03339102
What this trial is testing

Post-marketing Surveillance Study of Adalimumab (Humira®) for Non-infectious Intermediate, Posterior, or Panuveitis Patients

Who this might be right for
Non-infectious Intermediate, Posterior and Panuveitis
AbbVie 158
Large-scale testing (Phase 3)Study completedNCT00404742
What this trial is testing

LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis

Who this might be right for
Uveitis, PosteriorUveitis, IntermediatePanuveitis
Lux Biosciences, Inc. 232
Testing effectiveness (Phase 2)Ended earlyNCT05953688
What this trial is testing

POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU

Who this might be right for
Uveitis Posterior Non-InfectiousUveitis, IntermediateNoninfectious Panuveitis
Alumis Inc 36
Large-scale testing (Phase 3)Study completedNCT00333814
What this trial is testing

The Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis

Who this might be right for
Intermediate UveitisPosterior Uveitis
Allergan 229
Not applicableNot Yet RecruitingNCT05928754
What this trial is testing

Prospective CoHoRt Of Non-infectious Intermediate, pOsterior or panuveitiS

Who this might be right for
Non-infectious Uveitis
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 2,000
Not applicableActive Not RecruitingNCT07262437
What this trial is testing

Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine Profiles

Who this might be right for
Uveitis Posterior Non-InfectiousInflammation EyeUveitis+1 more
University of Milan 220
Testing effectiveness (Phase 2)Study completedNCT02929251
What this trial is testing

Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis

Who this might be right for
UveitisBiotherapy
Assistance Publique - Hôpitaux de Paris 112
Testing effectiveness (Phase 2)Study completedNCT01526889
What this trial is testing

Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,

Who this might be right for
Non-infectious Intermediate UveitisNon-infectious Posterior UveitisNon-infectious Panuveitis
Novartis Pharmaceuticals 25
Testing effectiveness (Phase 2)Study completedNCT04207983
What this trial is testing

A 48 Week Study to Evaluate the Efficacy and Safety of Two (2) EYS606 Treatment Regimens in Subjects With Active Chronic Non-infectious Uveitis (CNIU)

Who this might be right for
Non-infectious Uveitis
Eyevensys 3
Not applicableStudy completedNCT00403832
What this trial is testing

Acrylate Intraocular Lenses in Cataract Surgery of Uveitis Patients

Who this might be right for
UveitisCataract
St. Franziskus Hospital 60
Post-approval studies (Phase 4)UnknownNCT04426734
What this trial is testing

Evaluation of DEXTENZA in the Management of Pain and Inflammation in Patients With Anterior Uveitis Compared to Standard of Care Topical Corticosteroids

Who this might be right for
Non-infectious Anterior Uveitis
New England Retina Associates 30
Early research (Phase 1)Study completedNCT04018599
What this trial is testing

Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS

Who this might be right for
Rheumatoid ArthritisPolyarticular Juvenile Idiopathic ArthritisPsoriatic Arthritis+8 more
Fresenius Kabi SwissBioSim GmbH 216
Early research (Phase 1)Study completedNCT00280826
What this trial is testing

Efalizumab to Treat Uveitis

Who this might be right for
UveitisMacular Edema
National Eye Institute (NEI) 6
Testing effectiveness (Phase 2)UnknownNCT01717170
What this trial is testing

Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study

Who this might be right for
Intermediate UveitisPosterior UveitisPan-uveitis
University of Nebraska 36
Not applicableStudy completedNCT00790803
What this trial is testing

Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema

Who this might be right for
UveitisCystoid Macular Edema
Wake Forest University 5
Large-scale testing (Phase 3)Active Not RecruitingNCT07136805
What this trial is testing

VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis

Who this might be right for
Non-infectious Anterior Uveitis
VivaVision Biotech, Inc 154
Testing effectiveness (Phase 2)Study completedNCT04706741
What this trial is testing

A Trial of the Efficacy and Safety of Izokibep in the Treatment of Non-anterior Uveitis

Who this might be right for
Uveitis
ACELYRIN Inc. 7
Large-scale testing (Phase 3)Ended earlyNCT01032915
What this trial is testing

Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis

Who this might be right for
Non-infectious Uveitis
Novartis Pharmaceuticals 125
Large-scale testing (Phase 3)Study completedNCT00404612
What this trial is testing

LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis

Who this might be right for
Uveitis, PosteriorUveitis, IntermediatePanuveitis
Lux Biosciences, Inc. 218
Next Page